Bioequivalence and Bioavailability Forum 04:58 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Earth-mover's distance [Nonparametrics]

posted by ElMaestro - Denmark, 2017-10-27 14:58  - Posting: # 17933
Views: 1,881

Hi all,

re. FDA Ciclosporine draft guidance:

Does anyone know where I should start to get to grips with Earth-mover's distance for real and in practice?
Wikipedia, the reference indicated in the guidance and some random googling hasn't given me a solid basis for understanding anything, much less for doing anything of value with it.

Note that the footnote opens up the possibility of using some other statistical similarity measures, and I hope to go that way, but let us for the purpose of this thread discuss EMD only :-D:confused::pirate:

if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,698 posts in 3,983 threads, 1,237 registered users;
online 9 (0 registered, 9 guests [including 7 identified bots]).

When puzzled, it never hurts to read the primary documents –
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed